All papers - OPEN Foundation

Monoamine biosynthesis via a noncanonical calcium-activatable aromatic amino acid decarboxylase in psilocybin mushroom

Torrens-Spence, M. P., Liu, C. T., Pluskal, T., Chung, Y. K., & Weng, J. K. | ACS chemical biology | 28 November 2018

Self-Experiments with Psychoactive Substances: A Historical Perspective

Passie, T., & Brandt, S. D. | Handbook of Experimental Pharmacology | 27 November 2018

The effects of microdose LSD on time perception: a randomised, double-blind, placebo-controlled trial.

Yanakieva, S., Polychroni, N., Family, N., Williams, L. T., Luke, D. P., & Terhune, D. B. | Psychopharmacology | 26 November 2018

An exploratory study of experiences with conventional eating disorder treatment and ceremonial ayahuasca for the healing of eating disorders

Renelli, M., Fletcher, J., Tupper, K. W., Files, N., Loizaga-Velder, A., & Lafrance, A. | Eating and Weight Disorders-Studies on Anorexia, Bulimia and Obesity | 24 November 2018

Current perspectives on psychedelic therapy: use of serotonergic hallucinogens in clinical interventions

Garcia-Romeu, A., & Richards, W. A. | International Review of Psychiatry | 13 November 2018

Neuroimaging of chronic MDMA (“ecstasy”) effects: A meta-analysis

Müller, F., Brändle, R., Liechti, M. E., & Borgwardt, S. | Neuroscience & Biobehavioral Reviews | 12 November 2018

What Psilocybin Taught Me About Dying

Back, A. L. | Journal of palliative medicine | 9 November 2018

Acute effects of ayahuasca in a juvenile non-human primate model of depression

da Silva, F. S., Silva, E. A., Sousa Jr, G. M. D., Maia-de-Oliveira, J. P., Soares-Rachetti, V. D. P., de Araujo, D. B., ... & Galvão-Coelho, N. L. | Brazilian Journal of Psychiatry | 8 November 2018

Ayahuasca improves emotion dysregulation in a community sample and in individuals with borderline-like traits

Domínguez-Clavé, E., Soler, J., Pascual, J. C., Elices, M., Franquesa, A., Valle, M., ... & Riba, J. | Psychopharmacology | 7 November 2018

Predicting Responses to Psychedelics: A Prospective Study

Haijen, E. C. H. M., Kaelen, M., Roseman, L., Timmermann, C., Russ, S., Nutt, D., ... & Carhart-Harris, R. L. | Frontiers in pharmacology | 2 November 2018

Intravenous Ketamine for Adolescents with Treatment-Resistant Depression: An Open-Label Study

Cullen, K. R., Amatya, P., Roback, M. G., Albott, C. S., Westlund Schreiner, M., Ren, Y., ... & Reigstad, K. | Journal of child and adolescent psychopharmacology | 1 November 2018

Case Report: Ketamine for Pain and Depression in Advanced Cancer

Sexton, J., Atayee, R. S., & Bruner, H. C. | Journal of palliative medicine | 29 Oct 2018

Common neural signatures of psychedelics: Frequency-specific energy changes and repertoire expansion revealed using connectome-harmonic decomposition.

Atasoy, S., Vohryzek, J., Deco, G., Carhart-Harris, R. L., & Kringelbach, M. L. | Progress in brain research | 25 October 2018

Changes in global and thalamic brain connectivity in LSD-induced altered states of consciousness are attributable to the 5-HT2A receptor

Preller, K. H., Burt, J. B., Ji, J. L., Schleifer, C. H., Adkinson, B. D., Stämpfli, P., & Vollenweider, F. X. | eLife | 25 October 2018

Exploring the effect of microdosing psychedelics on creativity in an open-label natural setting

Prochazkova, L., Lippelt, D. P., Colzato, L. S., Kuchar, M., Sjoerds, Z., & Hommel, B. | Psychopharmacology | 25 October 2018

A case report SPECT study and theoretical rationale for the sequential administration of ibogaine and 5-MeO-DMT in the treatment of alcohol use disorder

Barsuglia, J. P., Polanco, M., Palmer, R., Malcolm, B. J., Kelmendi, B., & Calvey, T. | Progress in brain research | 25 October 2018

Psychedelic Moral Enhancement

Earp, B. D. | Royal Institute of Philosophy Supplements | 16 October 2018

Research ethics aspects of experimentation with LSD on human subjects: a historical and ethical review.

Bodnár, K. J., & Kakuk, P. | Medicine, Health Care and Philosophy | 16 October 2018

More Realistic Forecasting of Future Life Events After Psilocybin for Treatment-Resistant Depression

Lyons, T., & Carhart-Harris, R. L. | Frontiers in psychology | 12 October 2018

Ketamine and depression

Hirota, K. and Lambert, D. | British Journal of Anaesthesia | 12 October 2018 |

Ibogaine as a treatment for substance misuse: Potential benefits and practical dangers.

Corkery, J. M. | Progress in brain research | 12 October 2018

Kappa Opioid Receptor Agonist Mesyl Sal B Attenuates Behavioral Sensitization to Cocaine with Fewer Aversive Side-Effects than Salvinorin A in Rodents.

Kivell, B., Paton, K., Kumar, N., Morani, A., Culverhouse, A., Shepherd, A., ... & Prisinzano, T. | Molecules | 11 October 2018